Indication
Enterobacter cloacae bronchitis
*Enterobacter cloacae* bronchitis is a bacterial lower respiratory tract infection characterized by acute inflammation of the bronchial mucous membranes caused by *Enterobacter cloacae*, a facultatively anaerobic, Gram-negative bacillus. Read more about Enterobacter cloacae bronchitis
7 drugs 7 manufacturers
Drugs that treat it
Common Enterobacter cloacae bronchitis therapies.
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
AZTREONAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Enterobacter cloacae* bronchitis is a bacterial lower respiratory tract infection characterized by acute inflammation of the bronchial mucous membranes caused by *Enterobacter cloacae*, a facultatively anaerobic, Gram-negative bacillus.
Primarily affecting hospitalized patients, mechanically ventilated individuals, older adults, and persons with underlying chronic structural lung diseases or immunocompromising conditions, it reflects opportunistic colonization progressing to clinical infection.
Defining pathophysiologic and clinical features include bronchial mucosal hyperemia, excessive purulent sputum production, cough, dyspnea, and systemic inflammatory signs such as fever and leukocytosis.
Management is notably complicated by the intrinsic ability of *E.
cloacae* to produce inducible chromosomal AmpC beta-lactamases, which can drive resistance during therapy.
- nih.gov
*Enterobacter cloacae* bronchitis is a bacterial lower respiratory tract infection characterized by acute inflammation of the bronchial mucous membranes caused by *Enterobacter cloacae*, a facultatively anaerobic, Gram-negative bacillus Primarily affecting hospitalized patients, mechanically ventilated individuals, older adults, and persons with underlying chronic structural lung diseases or immunocompromising conditions, it reflects opportunistic colonization progressing to clinical infection M...
- fda.gov
*Enterobacter cloacae* bronchitis is a bacterial lower respiratory tract infection characterized by acute inflammation of the bronchial mucous membranes caused by *Enterobacter cloacae*, a facultatively anaerobic, Gram-negative bacillus
- nih.gov
Primarily affecting hospitalized patients, mechanically ventilated individuals, older adults, and persons with underlying chronic structural lung diseases or immunocompromising conditions, it reflects opportunistic colonization progressing to clinical infection
- dovepress.com
Primarily affecting hospitalized patients, mechanically ventilated individuals, older adults, and persons with underlying chronic structural lung diseases or immunocompromising conditions, it reflects opportunistic colonization progressing to clinical infection
- nih.gov
Defining pathophysiologic and clinical features include bronchial mucosal hyperemia, excessive purulent sputum production, cough, dyspnea, and systemic inflammatory signs such as fever and leukocytosis
- youtube.com
Defining pathophysiologic and clinical features include bronchial mucosal hyperemia, excessive purulent sputum production, cough, dyspnea, and systemic inflammatory signs such as fever and leukocytosis Management is notably complicated by the intrinsic ability of *E. cloacae* to produce inducible chromosomal AmpC beta-lactamases, which can drive resistance during therapy
Personalize your experience
Follow Enterobacter cloacae bronchitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.